Glenmark Receives FDA Approval to Market Generic Contraceptives in US

by Kathy Jones on  June 21, 2011 at 9:18 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Mumbai-based Glenmark Pharmaceuticals announced that its US subsidiary, Glenmark Generics, has won the approval from the US Food and Drug Administration to market its generic contraceptive pills in the country.
 Glenmark Receives FDA Approval to Market Generic Contraceptives in US
Glenmark Receives FDA Approval to Market Generic Contraceptives in US

According to the statement released by the company, the FDA has given its final approval for the manufacture of Norgestimate and Ethinyl Estradiol tablets in strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg and 0.25/0.035 mg.

"Glenmark remains the only Indian company to be granted ANDA approval for an oral contraceptive product and Monday's approval marks their fifth female hormonal product authorised for distribution by USFDA", the company said.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Birth Control Pills Intrauterine Device 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive